Next report date
Report period
Q1 2024
EPS estimate
−0.92EUR
Revenue estimate
123.44 MEUR
−2.32EUR
−331.86 MEUR
713.62 MEUR
133.94 M
About Ionis Pharmaceuticals, Inc.
Sector
CEO
Brett P. Monia
Headquarters
Carlsbad
Website
Employees (FY)
927
Founded
1989
FIGI
BBG006TLR1F0
Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. It operates through the Ionis Core segment. The Ionis Core segment exploits a novel drug discovery platform to generate a pipeline of drugs. The company was founded by Stanley T. Crooke, David J. Ecker, Christopher K. Mirabelli, and Brett P. Monia on January 10, 1989 and is headquartered in Carlsbad, CA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange IONIS PHARMACEUT. DL-001 stocks are traded under the ticker ISI.
IONIS PHARMACEUT. DL-001 is going to release the next earnings report on May 7, 2024. Keep track of upcoming events with our Earnings Calendar.
ISI earnings for the last quarter are −0.97 EUR per share, whereas the estimation was −0.95 EUR resulting in a −2.15% surprise. The estimated earnings for the next quarter are −0.73 EUR per share. See more details about IONIS PHARMACEUT. DL-001 earnings.
IONIS PHARMACEUT. DL-001 revenue for the last quarter amounts to 136.22 M EUR despite the estimated figure of 129.47 M EUR. In the next quarter revenue is expected to reach 157.76 M EUR.
Yes, you can track IONIS PHARMACEUT. DL-001 financials in yearly and quarterly reports right on TradingView.
ISI net income for the last quarter is −8.15 M EUR, while the quarter before that showed −139.45 M EUR of net income which accounts for 94.15% change. Track more IONIS PHARMACEUT. DL-001 financial stats to get the full picture.
No, ISI doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ISI shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade IONIS PHARMACEUT. DL-001 stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 26, 2024, the company has 927.00 employees. See our rating of the largest employees — is IONIS PHARMACEUT. DL-001 on this list?
We've gathered analysts' opinions on IONIS PHARMACEUT. DL-001 future price: according to them, ISI price has a max estimate of 80.00 EUR and a min estimate of 27.29 EUR. Read a more detailed IONIS PHARMACEUT. DL-001 forecast: see what analysts think of IONIS PHARMACEUT. DL-001 and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. IONIS PHARMACEUT. DL-001 EBITDA is −299.99 M EUR, and current EBITDA margin is −42.05%. See more stats in IONIS PHARMACEUT. DL-001 financial statements.